Gene therapy is at the forefront of curing severe and often debilitating genetic disorders. New enabling technologies such as viral- and non-viral vectors, oncolytic viruses, and CRISPR are giving R&D teams more ways to innovate. Modern gene therapy requires investigation of a wide variety of genes of interest, engineering of delivery vectors, and optimization of vector production processes.
This necessitates a strong digital foundation to comprehensively characterize gene therapy candidates to bring the best products into the clinic. Traceability must be maintained across sequences, samples, experiments, and processes to generate actionable insights.
Gene Therapy R&D Solution
Benchling’s Gene Therapy R&D Solution is trusted by leading gene therapy innovators to accelerate their R&D. It enables scientists to study gene editing and gene therapy technologies at scale with improved productivity, intuitive collaboration, and contextual insights. Our modern, digital solution combines the capabilities of traditional ELN, LIMS, and molecular biology tools in a unified cloud solution that natively supports gene therapy R&D.
Our Customer Experience professionals possess deep scientific expertise, as well as training on information technology best practices. They apply this know-how to support gene therapy customers across a wide range of R&D teams.
Leverage Benchling's pre-implementation solutions consulting, professional implementation services, and customer success management expertise to help you get the most out of Benchling.
Take advantage of Benchling’s foundational implementation guides, developed by our Customer Experience team to support many gene therapy R&D functions, including:
CRISPR gene editing